to detect bacteremia in patients with febrile neutropenia. PLoS One. 2018;13(5):e0197049. \[[PMC free article: PMC5955575](/pmc/articles/PMC5955575/)\] \[[PubMed: 29768470](https://pubmed.ncbi.nlm.nih.gov/29768470)\] 11. Arientová S, Beran O, Štefan M, Čurdová M, Holub M. Bacteremia due to Staphylococcus aureus - the importance of appropriate management. Epidemiol Mikrobiol Imunol. 2018 Spring;67(2):88-91. \[[PubMed: 30126286](https://pubmed.ncbi.nlm.nih.gov/30126286)\] 12. Banik A, Bhat SH, Kumar A, Palit A, Snehaa K. Bloodstream infections and trends of antimicrobial sensitivity patterns at Port Blair. J Lab Physicians. 2018 Jul-Sep;10(3):332-337. \[[PMC free article: PMC6052817](/pmc/articles/PMC6052817/)\] \[[PubMed: 30078972](https://pubmed.ncbi.nlm.nih.gov/30078972)\] 13. Rapoport AB, Fischer LS, Santibanez S, Beekmann SE, Polgreen PM, Rowley CF. Infectious Diseases Physicians' Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017. Open Forum Infect Dis. 2018 Jul;5(7):ofy132. \[[PMC free article: PMC6041812](/pmc/articles/PMC6041812/)\] \[[PubMed: 30018999](https://pubmed.ncbi.nlm.nih.gov/30018999)\] 14. Beeler C, Dbeibo L, Kelley K, Thatcher L, Webb D, Bah A, Monahan P, Fowler NR, Nicol S, Judy-Malcolm A, Azar J. Assessing patient risk of central line-associated bacteremia via machine learning. Am J Infect Control. 2018 Sep;46(9):986-991. \[[PubMed: 29661634](https://pubmed.ncbi.nlm.nih.gov/29661634)\] 15. Morrison T. eNews Tool to Prevent Central Line-Associated Bloodstream Infection. Comput Inform Nurs. 2018 Apr;36(4):161-165. \[[PubMed: 29620619](https://pubmed.ncbi.nlm.nih.gov/29620619)\] 16. Mogle BT, Steele JM, Seabury RW, Dang UJ, Kufel WD. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Int J Antimicrob Agents. 2018 Dec;52(6):805-810. \[[PubMed: 30176357](https://pubmed.ncbi.nlm.nih.gov/30176357)\] 17. Chen SY, Lee H, Wang XM, Lee TF, Liao CH, Teng LJ, Hsueh PR. High mortality impact of Staphylococcus argenteus on patients with community-onset staphylococcal bacteraemia. Int J Antimicrob Agents. 2018 Dec;52(6):747-753. \[[PubMed: 30149137](https://pubmed.ncbi.nlm.nih.gov/30149137)\] 18. Bidell MR, Patel N, O'Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. J Antimicrob Chemother. 2018 Oct 01;73(10):2643-2651. \[[PubMed: 30085140](https://pubmed.ncbi.nlm.nih.gov/30085140)\] **Disclosure:** David Smith declares no relevant financial relationships with ineligible companies. **Disclosure:** Sara Nehring declares no relevant financial relationships with ineligible companies.